New Poll: Huge Majorities Want Medicare to Cover Cost of Alzheimer’s Drugs
Americans want Congress and the president to step in if CMS doesn’t change its restrictive coverage policy
Patients and Caregivers Now Have Option for Treating Alzheimer’s-Related Agitation
The Alzheimer’s community is applauding the decision by the Food and Drug Administration to approve the use of a medication to treat Alzheimer’s-related agitation.
Brain Health Academy Enrollment is Now Open
Free continuing education program for health and wellness professionals adds six new monthly sessions on modifiable risk factors including obesity, diabetes, hearing loss, depression, smoking, and alcohol use. Next Session: Obesity & Dementia, May 17
More Promising News for People Living with Alzheimer's
Patients Cheer Phase 3 clinical trials showing new drug slows decline compared to placebo
Say Hello to BrainGuide
Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.
UsAgainstAlzheimer’s: Power of Us
Get to know UsAgainstAlzheimer’s, what we’ve accomplished, and where we’re headed through our powerful video introduction.
mericans strongly support requiring Medicare to cover FDA-approved treatments for the disease.
Patients and Caregivers Now Have Option for Treating Alzheimer’s-Related Agitation
The Brain Health Academy
More Promising News for People Living with Alzheimer's
Say Hello to BrainGuide
UsAgainstAlzheimer’s: Power of Us

UsAgainstAlzheimer's: Working to End Alzheimer's Disease
The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.
UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.
We bring all of “Us” together to:
- Improve brain health and promote earlier detection, diagnosis and intervention
- Champion health equity and access for communities of color and women who are disproportionately impacted by the disease
- Advocate for increased research spending that will speed treatments to market
- Drive changes that matter most to people living with the disease and caregivers
In the past decade, progress has been made, with more hope on the horizon now than ever before.
But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.